In the latest session, 89bio Inc (NASDAQ: ETNB) closed at $9.49 down -3.36% from its previous closing price of $9.82. On the day, 670898 shares were traded.
Ratios:
For a deeper understanding of 89bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.04 and its Current Ratio is at 20.04. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on January 12, 2024, Downgraded its rating to Sector Perform and sets its target price to $15 from $24 previously.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $36.UBS initiated its Buy rating on August 28, 2023, with a $36 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 01 ’24 when PALEKAR ROHAN sold 52,718 shares for $10.91 per share. The transaction valued at 575,153 led to the insider holds 459,171 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 1,350,000 shares of ETNB for $20,722,500 on Mar 04 ’24. The Director now owns 12,431,584 shares after completing the transaction at $15.35 per share. On Feb 26 ’24, another insider, PALEKAR ROHAN, who serves as the Chief Executive Officer of the company, sold 4,477 shares for $10.76 each. As a result, the insider received 48,173 and left with 486,889 shares of the company.
Stock Price History:
Over the past 52 weeks, ETNB has reached a high of $22.93, while it has fallen to a 52-week low of $6.57.
Shares Statistics:
A total of 93.27M shares are outstanding, with a floating share count of 86.96M. Insiders hold about 7.00% of the company’s shares, while institutions hold 102.25% stake in the company.
Earnings Estimates
There are Enbridge Inc different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $315.28, with high estimates of $45.94 and low estimates of $0.20.
Analysts are recommending an EPS of between $Technology and $Healthcare for the fiscal current year, implying an average EPS of $Industrials.
